<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Molecular tests for encephalitis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Molecular tests for encephalitis</h1>
<div class="graphic"><div class="figure"><div class="ttl">Molecular tests for encephalitis</div><div class="cntnt"><table cellspacing="0"><colgroup width="30%"></colgroup><colgroup width="10%"></colgroup><colgroup span="2" width="30%"></colgroup> <tbody> <tr> <td class="subtitle1">Etiology</td> <td class="subtitle1">Availability<sup>*</sup></td> <td class="subtitle1">When inclusion of NAT is indicated</td> <td class="subtitle1">Preferred testing method(s)<sup>¶</sup></td> </tr> <tr> <td class="subtitle2_left" colspan="4">Bacteria</td> </tr> <tr> <td class="indent1"><em>Coxiella burnetti</em> (Q fever)</td> <td>Yes</td> <td>When clinically suspected</td> <td>NAT, serology</td> </tr> <tr> <td class="indent1"><em>Listeria</em> spp</td> <td>Yes<sup>Δ</sup></td> <td>Rarely</td> <td>Culture, +/– NAT and serology</td> </tr> <tr> <td class="indent1"><em>Mycobacterium tuberculosis<sup></sup></em><sup>◊</sup></td> <td>Yes</td> <td>Potentially</td> <td>AFB stain, culture, histologic exam, and NAT</td> </tr> <tr class="divider_bottom"> <td class="indent1">Fastidious organisms (<em>Mycoplasma</em> spp, <em>Bartonella</em> spp)</td> <td>Yes</td> <td>When clinically suspected, especially in children</td> <td>Serology, NAT including alternative sites where appropriate (eg, respiratory)</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Viruses</td> </tr> <tr> <td class="indent1">Adenoviruses</td> <td>Yes</td> <td>Rarely</td> <td>Testing of alternative sites (eg, respiratory) +/– CSF</td> </tr> <tr> <td class="indent1">Arboviruses</td> <td>Limited</td> <td>When clinically suspected</td> <td>Serology (+/- NAT in selected cases)<sup>§</sup></td> </tr> <tr> <td class="indent1">Epstein-Barr virus</td> <td>Yes</td> <td>When clinically suspected</td> <td>Serology and NAT, preferably quantitative</td> </tr> <tr> <td class="indent1">Enteroviruses</td> <td>Widespread<sup>Δ</sup></td> <td>When clinically suspected</td> <td>NAT</td> </tr> <tr> <td class="indent1">Human herpesvirus 6</td> <td>Yes<sup>Δ</sup></td> <td>When clinically suspected</td> <td>NAT, preferably quantitative</td> </tr> <tr> <td class="indent1">Herpes simplex virus</td> <td>Widespread<sup>Δ</sup></td> <td>When clinically suspected</td> <td>NAT</td> </tr> <tr> <td class="indent1">Influenza</td> <td>Yes</td> <td>Rarely</td> <td>Testing of alternative sites (eg, respiratory) +/– CSF</td> </tr> <tr> <td class="indent1">Lymphocytic choriomeningitis virus</td> <td>Limited</td> <td>Rarely</td> <td>Serology</td> </tr> <tr> <td class="indent1">Mumps</td> <td>Limited</td> <td>Rarely</td> <td>History, culture, serology, and NAT</td> </tr> <tr> <td class="indent1">Parechoviruses<sup>¥</sup></td> <td>Yes<sup>Δ</sup></td> <td>Primarily in young children (&lt;5 years old)</td> <td>NAT</td> </tr> <tr> <td class="indent1">Rabies<sup>‡</sup></td> <td>Limited (CDC)</td> <td>When clinically suspected</td> <td>Combination of serology, biopsy, NAT</td> </tr> <tr> <td class="indent1">Varicella-zoster virus</td> <td>Yes<sup>Δ</sup></td> <td>When clinically suspected</td> <td>NAT (plus CSF serology in selected cases)<sup>†</sup></td> </tr> <tr class="divider_bottom"> <td class="indent1">West Nile virus**</td> <td>Yes</td> <td>Rarely (unless immunodeficient)</td> <td>Serology</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Fungal</td> </tr> <tr> <td class="indent1"><em>Cryptococcus</em></td> <td>Yes<sup>Δ</sup></td> <td>No</td> <td>Antigen detection, culture</td> </tr> <tr class="divider_bottom"> <td class="indent1">Other fungi</td> <td>Limited</td> <td>No</td> <td>Culture, serology, histologic exam</td> </tr> <tr> <td class="subtitle2_left">Rickettsia<sup>¶¶</sup></td> <td class="divider_bottom">Limited</td> <td class="divider_bottom">Occasionally</td> <td class="divider_bottom">Serology</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Spirochetes</td> </tr> <tr> <td class="indent1"><em>Borrelia burgdorferi</em> (the agent of Lyme disease)</td> <td>Yes</td> <td>Rarely</td> <td>Serology</td> </tr> <tr class="divider_bottom"> <td class="indent1"><em>Treponema pallidum</em> (syphilis)</td> <td>Limited</td> <td>When clinically suspected</td> <td>Serology, CSF VDRL</td> </tr> <tr> <td class="subtitle2_left" colspan="4">Parasites</td> </tr> <tr> <td class="indent1">Microsporidia</td> <td>Limited</td> <td>Rarely</td> <td>Serology, stains, histologic exam</td> </tr> <tr> <td class="indent1">Free-living amebae (eg, <em>Naegleria fowleri</em>)</td> <td>Limited</td> <td>When clinically suspected</td> <td>CSF wet mount and NAT</td> </tr> <tr> <td class="indent1">Other parasites (<em>Baylisascaris </em>spp, <em>Balamuthia mandrillaris</em>)</td> <td>Limited</td> <td>Rarely (eg, CSF eosinophilia)</td> <td>Histologic exam, serology +/– NAT</td> </tr> </tbody></table></div><div class="graphic_footnotes">PPV: positive predictive value; CDC: Centers for Disease Control and Prevention; HHV-6: human herpesvirus 6; NAT: nucleic acid amplification testing; CSF: cerebrospinal fluid; AFB: acid-fast bacilli; VDRL: Venereal Disease Research Laboratories; FDA: US Food and Drug Administration.<br/>* Widespread: readily available; Yes: consistently available, but not yet common; Limited: one or two specialized laboratories (eg, CDC or research groups).<br/>¶ Test on CSF except where noted.<br/>Δ Also available as part of FDA-cleared  multiplex NAT at some centers and referral laboratories.<br/>◊ Limited experience, presumably variable sensitivity, high PPV.<br/>§ NAT may be useful for diagnosis in immunocompromised patients.<br/>¥ Not detected by most enterovirus assays.<br/>‡ In conjunction with other modalities.<br/>† CSF serology should be performed when clinical suspicion for herpes zoster is high and the presentation is subacute (eg, VZV vasculopathy or onset of CNS symptoms following recent episode of zoster).<br/>** Virus is usually cleared from blood and CSF prior to symptom onset.<br/>¶¶ Limited experience from CSF.</div><div id="graphicVersion">Graphic 80353 Version 12.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
